Metraipolis › archive › dc_73d9a8a9366c
4-Aminopyridine — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/4-Aminopyridine
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T15:49:34.374Z
- SHA-256 of the archived text
317114b396af6feeb268f5624ab7cab0b8a651005802d10d4279b2c657ae430b- Stable URL of this page
https://metraipolis.com/documento/dc_73d9a8a9366c
How to cite
4-Aminopyridine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/4-Aminopyridine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_73d9a8a9366c (Metraipolis archive dc_73d9a8a9366c, sha256 317114b396af6feeb268f5624ab7cab0b8a651005802d10d4279b2c657ae430b)
BibTeX
@misc{dc73d9a8a9366c,
title = {4-Aminopyridine — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/4-Aminopyridine},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_73d9a8a9366c; sha256 317114b396af6feeb268f5624ab7cab0b8a651005802d10d4279b2c657ae430b},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/4-Aminopyridine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
4-Aminopyridine (4-AP, fampridine, dalfampridine) is an organic compound with the chemical formula H2NC5H4N. It is one of the three isomeric aminopyridines. It is used as a research tool in characterizing subtypes of the potassium channel. It has also been used as a drug, to manage some of the symptoms of multiple sclerosis, and is indicated for symptomatic improvement of walking in adults with several variations of the disease. It was undergoing Phase III clinical trials as of 2008, and the U.S. Food and Drug Administration (FDA) approved the compound on January 22, 2010. 4-AP has been used as treatment for KCNA2-related disorders with gene mutations that show a clear gain-of-function. Benefits include decreased seizures and improved ataxia, alertness, and cognition. Fampridine is also marketed as Ampyra (pronounced "am-PEER-ah", according to the maker's website) in the United States by Acorda Therapeutics and as Fampyra in the European Union, Canada, and Australia. In Canada, the medication has been approved for use by Health Canada since February 10, 2012. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «4-Aminopyridine» — https://en.wikipedia.org/wiki/4-Aminopyridine Wikidata Q372539: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q372539 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/4-Aminopyridine?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1365528289, consultata il 2026-11-06T15:40:35.617Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: d7b00d912cb2b3e5307ac542f08b1f71e60137412ce9f29ba494cef99c9fe782